Literature DB >> 3713922

Tumor associated macrophage mediated lysis of autologous tumor cells.

U Chattopadhyay, S Bhattacharyya, N G Chakrabarty.   

Abstract

Lysis of autologous tumor cells (ATC) mediated by the tumor associated macrophages (TAM) was studied by 4 h 51Cr-release assay at different days of growth of a transplantable ascites tumor, S-180, inoculated in adult male Swiss mice. The ATC were coated with serum of tumor bearing mice. On day 3 after tumor inoculation the TAM mediated a remarkable lysis of the tumor serum coated ATC. With advancement of tumor growth the cytolysis by TAM decreased gradually to the basal level at day 10 and totally abrogated at day 12. Also the binding of the tumor serum coated ATC by TAM varied at different days of tumor growth. At early phases of tumor growth high lytic activity of the TAM was correlated with augmented target binding. The observed lysis may be considered as antibody dependent cell mediated cytotoxicity (ADCC) extended by the TAM, since presence of specific tumor antibodies were demonstrated in the tumor serum used for coating ATC. No significant lysis was recorded when the ATC was coated with normal serum or used as such for direct lysis by the TAM. In vitro treatment of the TAM with suitable doses of Levamisole and Polyionosinic-polycyticyclic acid further augmented the TAM mediated high level of ADCC at day 3 with no change in its binding of ATC. The immunopotentiators enhanced both ADCC and target binding ability of the functionally depressed TAM at day 10.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3713922

Source DB:  PubMed          Journal:  Neoplasma        ISSN: 0028-2685            Impact factor:   2.575


  4 in total

1.  Human and murine Kupffer cell function may be altered by both intrahepatic and intrasplenic tumor deposits.

Authors:  S Meterissian; G D Steele; P Thomas
Journal:  Clin Exp Metastasis       Date:  1993-03       Impact factor: 5.150

2.  Tumoricidal effect of human macrophage-colony-stimulating factor against human-ovarian-carcinoma-bearing athymic mice and its therapeutic effect when combined with cisplatin.

Authors:  T Adachi; H Mano; Y Shinohara; T Nakanishi; T Suzuki; K Ino; N Kato; T Okamoto; A Nawa; S Goto
Journal:  Cancer Immunol Immunother       Date:  1993-07       Impact factor: 6.968

3.  Manipulating the NF-κB pathway in macrophages using mannosylated, siRNA-delivering nanoparticles can induce immunostimulatory and tumor cytotoxic functions.

Authors:  Ryan A Ortega; Whitney Barham; Kavya Sharman; Oleg Tikhomirov; Todd D Giorgio; Fiona E Yull
Journal:  Int J Nanomedicine       Date:  2016-05-18

4.  Prevention of Prostate Tumor Development by Stimulation of Antitumor Immunity Using a Standardized Herbal Extract (Deep Immune®) in TRAMP Mice.

Authors:  Peihe Liang; Jia Guo; Shadan Li; Qiunong Guan; Terry Vanderheyden; Alan So; Yuzhuo Wang; Tao Chen; Caigan Du
Journal:  Evid Based Complement Alternat Med       Date:  2018-05-14       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.